InvestorsHub Logo
Followers 5
Posts 406
Boards Moderated 0
Alias Born 11/23/2014

Re: None

Monday, 03/06/2017 8:36:59 PM

Monday, March 06, 2017 8:36:59 PM

Post# of 3878
A few things from the 20-F annual report for 2016.

1) They expect to file an NDA for Riazport in third quarter of 2017.

2) They terminated the exclusive option agreement for RP101 (no longer under development, wish they would explain why)

3) They terminated the exclusive option agreement for RHB-101 (Why? What happened?)

I am glad they are focusing on what they can afford to develop, and perhaps that is where they are going with the option agreement terminations.

What would be great is to have a story similar to Knight Therapeutics where they are basically self funding after making some great deals. We'll see what happens in the next year and if they can bag a couple more co-promotion deals.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News